Although financial gloom is everywhere and President Trump is triggering a rumpus with his 'America first' technique, the UK stock exchange remains unfazed.

Despite a few wobbles last week - and more to come as Trump rattles global cages - both the FTSE100 and broader FTSE All-Share indices have been durable.

Both are more than 13 percent higher than this time last year - and near to tape-record highs.

Against this backdrop of economic uncertainty, Trump rhetoric and near-market highs, it's difficult to believe that any outstanding UK investment chances for client financiers exist - so called 'recovery' circumstances, where there is potential for the share price of particular companies to increase like a phoenix from the ashes.

But a band of fund managers is specialising in this contrarian kind of investing: purchasing underestimated companies in the expectation that with time the market will reflect their true worth.

This undervaluation may arise from bad management resulting in mistakes; an unfriendly economic and monetary background; or wider issues in the market in which they run.

Rising like a phoenix: Buying underestimated companies in the hope that they'll ultimately skyrocket needs nerves of steel and infinite persistence

Yet, the fund supervisors who purchase these shares think the 'problems' are solvable, although it may take up to five years (occasionally less) for the outcomes to be shown in far higher share prices. Sometimes, to their dismay, the problems prove unsolvable.

Max King invested 30 years in the City as an investment manager with the likes of J O Hambro Capital Management and Investec. He says investing for healing is high risk, requires persistence, a neglect for consensus financial investment thinking - and nerves of steel.

He likewise believes it has actually become crowded out by both the expansion in low-cost passive funds which track specific stock exchange indices - and the appeal of development investing, constructed around the success of the big tech stocks in the US.

Yet he insists that recovery investing is far from dead.

In 2015, King states many UK recovery stocks made investors sensational returns - consisting of banks NatWest and Barclays (still recuperating from the 2008 worldwide monetary crisis) and aerospace and defence giant Rolls-Royce Holdings (flourishing again after the effect of the 2020 pandemic lockdown). They created particular returns for investors of 83, 74 and 90 percent.

Some shares, says King, have more to use investors as they advance from healing to development. 'Recovery financiers frequently purchase too early,' he states, 'then they get bored and offer too early.'

But more notably, he believes that new healing chances always provide themselves, even in an increasing stock exchange. For brave investors who purchase shares in these recovery situations, excellent returns can lie at the end of the rainbow.

With that in mind, Wealth asked 4 leading fund supervisors to recognize the most engaging UK recovery chances.

They are Ian Lance, manager of investment trust Temple Bar and Alex Wright who runs fund Fidelity Special Situations and trust Fidelity Special Values. These two managers accept the healing investment thesis 100 per cent.

Completing the quartet are Laura Foll, who with James Henderson runs the financial investment portfolio of trust Law Debenture, and Imran Sattar of financial investment trust Edinburgh.

These two supervisors purchase recovery stocks when the investment case is compelling, however only as part of more comprehensive portfolios.

Can you make a fortune wagering that shares in our biggest ... Why has the FTSE 100 hit record highs? INVESTING SHOW

How to select the finest (and least expensive) stocks and shares Isa and the ideal DIY investing account

' Recovery stocks remain in our DNA,' states Lance who runs the ₤ 800 million Temple Bar with Nick Purves. 'The logic is basic. A company makes a strategic mistake - for instance, a bad acquisition - and their share cost gets cratered. We buy the shares and then wait for a catalyst - for instance, a change in management or business strategy - which will transform the company's fortunes.

' Part of this process is talking to the company. But as a financier, you need to be client.'

Recent success stories for Temple consist of Marks & Spencer which it has owned for the past five years and whose shares are up 44 percent over the past year, 91 percent over the previous 5.

Fidelity's Wright states buying healing shares is what he does for a living. 'We purchase unloved companies and after that hold them while they ideally undergo positive modification,' he explains.

' Typically, any recovery in the share price takes in between 3 and 5 years to come through, smfsimple.com although periodically, as taken place with insurance company Direct Line, the healing can come quicker.'

In 2015, Direct Line's board accepted a takeover deal from competing Aviva, valuing its shares at ₤ 2.75. As a result, its shares increased more than 60 percent.

Foll states healing stocks 'are often huge chauffeurs of portfolio efficiency'. The very best UK ones, lespoetesbizarres.free.fr she says, are to be found amongst underperforming mid-cap stocks with a domestic organization focus.

Sattar says Edinburgh's portfolio is 'diverse' and 'all weather' with an emphasis on premium firms - it's awash with FTSE100 stocks.

So, healing stocks are only a slivver of its assets.

' For us to purchase a recovery stock, it should be very first and primary a great company.'

So, here are our investment specialists' top picks. As Lance and Wright have actually said, they may take a while to make good returns - and nothing is guaranteed in investing, especially if Labour continues to make a pig's ear of stimulating financial development.

But your perseverance could be well rewarded for welcoming 'recovery' as part of your long-lasting financial investment portfolio.

> Look for the stocks below, latest performance, yield and more in This is Money's share centre

WINNERS IN A POSSIBLE HOME BUILDING BOOM Marshalls is the country's leading supplier of building, landscaping, and roofing items - buying roofing expert Marley 3 years ago.

Yet it has actually struggled to grow income against the backdrop of 'difficult markets' - last month it said its profits had fallen ₤ 52million to ₤ 619 million in 2024.

The share price has gone no place, falling 10 and 25 percent over the past one and 2 years.

Yet, lower interest rates - a 0.25 per cent cut was announced by the Ban > k of England last Thursday - and the conference of a yearly housebuilding target of 300,000 set by Chancellor Rachel Reeves may help fire up Marshalls' share cost.

Law Debenture's Foll says any pick-up in housebuilding must lead to a need surge for Marshalls' items, streaming through to higher revenues. 'Shareholders might delight in appealing overall returns,' she says, 'although it may take a while for them to come through.' Edinburgh's Sattar likewise likes Marshalls although, unlike Foll who already holds the business's shares in Law Debenture's portfolio, it is only on his 'radar'.

He says: 'Its sales volumes are still listed below pre-pandemic levels. If the Chancellor does her bit to re-

fire up housebuilding, then it ought to be a beneficiary as a provider of products to new homes.'

Sattar likewise has an eye on builders' merchant Travis Perkins which he has actually owned in the past. 'It has fresh management on board [a brand-new chairman and president] and I have a meeting with them shortly,' he states.

' From a financial investment viewpoint, it's a choices and shovels approach to gaining from any growth in the real estate market which I choose to buying shares in specific housebuilders.'

Like Marshalls, Travis Perkins' shares have gone nowhere, falling by 7, 33 and 50 percent over one, two and 3 years.

Another beneficiary of a possible housebuilding boom is brick producer Ibstock. 'The company has actually big repaired expenses as a result of heating the big kilns required to make bricks,' states Foll.

' Any uptick in housebuilding will increase brick production and sales, having an overstated advantage on its operating expenses.'

Lower rate of interest, she adds, should also be a positive for Ibstock. Although its shares are 14 percent up over the past year, they are up a meagre 0.3 percent over two years, and down 11 and 42 per cent over 3 and five years.

Fidelity's Wright has also been buying shares in two business which would gain from an improvement in the real estate market - kitchen supplier Howden Joinery Group and retailer DFS Furniture.

Both companies, he says, are gaining from having a hard time competitors. In Howden's case, wolvesbaneuo.com rival Magnet has actually been closing showrooms, while DFS competitor SCS was bought by Italy's Poltronesofa, which then closed numerous SCS stores for repair.

DFS, a Midas pick last month, has actually seen its share price increase by 17 per cent over the past year, but is still down 41 percent over three years. Howden, a constituent of the FTSE 100, has actually made gains of 6 percent over both one and 3 years.

Six lessons from the pandemic stock market era, by investing guru TOM STEVENSON

FUND MANAGER WORTH MORE THAN ITS PARTS Temple Bar's Lance does not mince his words when speaking about FTSE250-listed fund supervisor Abdrn. 'People are right when they explain it as a rather struggling fund management company,' he states.

'Yet what they frequently do not realise is that it likewise owns a successful investment platform in Interactive Investor and a consultant service that, integrated, validate its market capitalisation. In effect, the market is putting little worth on its fund management service. '

Add in a pension fund surplus, a huge multi-million-pound stake in insurance provider Phoenix - and Lance says shares in Abrdn have 'great healing potential'.

Temple Bar took a stake in business at the tail end of last year. Lance is excited by the business's brand-new management group which is intent on cutting costs.

Over the previous one and 3 years, the shares are down 3 and 34 per cent, respectively.

OTHER RECOVERY POSSIBILITIES Fidelity's Wright states a recovery stock tends to go through 3 unique phases.

First, a company starts favorable modification (phase one, when the shares are dirt cheap). Then, the stock exchange acknowledges that change remains in development (stage 2, shown by an increasing share price), and finally the cost fully shows the modifications made (phase 3 - and time to consider selling).

Among those shares he keeps in the phase one container (the most interesting from a financier viewpoint) is advertising giant WPP. Wright purchased WPP in 2015 for Special Values and Special Situations.

Over one, 2 and three years, its shares are respectively up by 1 percent and down by 22 and 33 per cent.

'WPP's shares are low-cost due to the fact that of the tough advertising background and issues over the possible disruptive impact of synthetic intelligence (AI) on its profits,' he says. 'But our analysis, based in part on speaking with WPP clients, indicates that AI will not interrupt its service model.'

Other healing stocks mentioned by our professionals include engineering giant Spirax Group. Its shares are down 21 percent over the previous year, but Edinburgh's Sattar says it is a 'dazzling UK industrial organization, global in reach'.

He is also a fan of bug control giant Rentokil Initial which has actually experienced duplicated 'missteps' over its expensive 2022 acquisition of US business Terminix.

Sattar holds both stocks in the ₤ 1.1 billion trust.